To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks

NCT02377609 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2015-05-15

No results posted yet for this study

Summary

The principal aim of this study is to define the relationship between tacrolimus concentrations determined from the finger prick DBS (Dry Blood Spot) method and those determined from blood samples collected by venepuncture in transplant recipients.

Conditions

  • Validation
  • Dried Blood Spot
  • Transplant Patients

Interventions

DRUG

Tacrolimus

oral

Sponsors & Collaborators

  • Astellas Pharma Europe Ltd.

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Europe Ltd.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • France
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377609 on ClinicalTrials.gov